NextCure, Inc.

NXTC • NASDAQ • Stock Fundamentals

NextCure, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Michael S. Richman, with a market cap of $8.1M.

Market Cap$8.1M

Employees82.0

CEOMichael S. Richman

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 7, 2026 · 1 month 7 days agoQ1 2026

Next EarningsAug 6, 2026 · in 2 monthsBefore Market Open · Q2 2026

Financials

Based on Q1 2026 filing

NXT

Common questions about NextCure, Inc.

NextCure, Inc. (NXTC) has a market capitalization of $8.1M and trades on NASDAQ.

NextCure, Inc. has approximately 82 employees.